Quarterly Result13 Feb 2026, 12:30 pm
Transgene Biotek Ltd Approves Q3 Financial Results for 2025
AI Summary
Transgene Biotek Ltd has approved its unaudited Consolidated & Stand- alone Financial Results for the quarter ended 31.12.2025. The company's Board has considered and approved the results in accordance with the Indian Accounting Standards (IND-AS) as per Companies (Indian Accounting Standards) Rules, 2015. A Limited Review Report on the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 31.12.2025 has also been approved.
Key Highlights
- Transgene Biotek Ltd has approved its unaudited Consolidated & Stand- alone Financial Results for Q3 2025.
- The results have been prepared in accordance with the Indian Accounting Standards (IND-AS) as per Companies (Indian Accounting Standards) Rules, 2015.
- A Limited Review Report on the Unaudited Standalone and Consolidated Financial Results of the Company for Q3 2025 has been approved.
- The review was conducted by M/S VASAVI & CO INDIA Chartered Accountants.
- The review report confirms that the financial statements are free of material misstatement and disclose the information required by Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Price Impact
More from TRABI